Transcription factors, particularly hypoxia-inducible factor 1-alpha (HIF-1α), also play a central role in metabolic reprogramming by activating genes involved in glycolysis and lactate fermentation under low oxygen conditions, contributing to tumor aggressiveness and drug resistance (D'Aguanno et al., 2021). The gene discussed is HIF1A; the disease is neoplasm.